Biotech Group Acquisition Corp

Biotech Group Acquisition Corp (BGAC) is a blank-check company focused on the biotechnology and life sciences sector that completed its initial public offering in 2022. The company filed an amended S-1 registration statement with the U.S. Securities and Exchange Commission on July 22, 2022, as part of its IPO process, carrying accession number 0001213900-22-040971. BGAC was formed with a sector-focused mandate to identify and complete a business combination with a target operating in the biotech or broader healthcare industry. The SPAC's current deal status and any announced combination targets are tracked on SpacDesk — sign up for full data access and filing alerts on BGAC.